CSBR - Champions Oncology - Stock Forecast

Healthcare - Sector

Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

Champions Oncology's activity chart (see below) currently has 6 price targets and 6 ratings on display.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 66.67% with an average time for these price targets to be met of 265 days.

Most recent stock forecast was given by MATT HEWITT from CRAIG HALLUM on 12-Mar-2025. First documented stock forecast 20-Sep-2019.

Scott Henry Matt Hewitt

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy Since 12-Dec-2024

$12

$7.1 (144.90%)

1 years 6 months 20 days ago
(12-Mar-2025)

1/2 (50%)

$2.45 (25.65%)

Buy Since 20-Sep-2019

$10

3 years 10 days ago
(22-Sep-2023)

2/2 (100%)

$1.44 (16.82%)

171

Show more analysts

What is CSBR (Champions Oncology) average time for price targets to be met?

On average it took 265 days for the stock forecasts to be reached, with an average price target met ratio of 66.67%.

Which analyst most recently updated their price target on CSBR (Champions Oncology)?

Matt Hewitt

Which analyst has the most public recommendations on CSBR (Champions Oncology)?

Matt Hewitt works at CRAIG HALLUM and has 2 price targets and 2 ratings on CSBR

Which analyst is the currently most bullish on CSBR (Champions Oncology)?

Matt Hewitt with the highest potential upside of $7.1

Which analyst is the currently most reserved on CSBR (Champions Oncology)?

Scott Henry with the lowest potential downside of -$0